Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Dr. Lal PathLabs Limited

Market Cap 270B 2.86B 2.46B 2.27B 2.13B 4B 4.04B 26.81B 10.47B 132B 10.73B 10.5B 458B P/E Ratio 2026
43.2x
P/E Ratio 2027 * 45.8x
Enterprise Value 258B 2.73B 2.35B 2.16B 2.03B 3.81B 3.85B 25.59B 10B 126B 10.24B 10.02B 437B EV / Sales 2026
7.45x
EV / Sales 2027 * 8.15x
Free-Float
44.94%
Yield 2026 *
0.87%
Yield 2027 * 1.12%
1 day+0.91%
1 week+5.15%
Current month+0.54%
1 month+0.99%
3 months+19.25%
6 months+12.44%
Current year+9.00%
1 week 1,543
Extreme 1543
1,634
1 month 1,500.1
Extreme 1500.1
1,719.9
Current year 1,272.6
Extreme 1272.6
1,719.9
1 year 1,272.6
Extreme 1272.6
1,770
3 years 971.85
Extreme 971.85
1,826.98
5 years 881.02
Extreme 881.025
2,122.75
10 years 361.52
Extreme 361.525
2,122.75
Manager TitleAgeSince
Chief Executive Officer - 2024-05-20
Director of Finance/CFO - 2018-08-09
Chief Operating Officer - 2022-03-31
Director TitleAgeSince
Director/Board Member 60 2023-07-26
Director/Board Member 79 2015-08-20
Chairman 75 2020-03-31
Date Insider Type Main position Quantity % Market Cap.
25-09-23Buy 750 0.0009%
25-09-18Buy 750 0.0009%
25-09-18Sell 350 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+0.91%+5.15%+9.43%+61.82% 2.82B
+2.57%+0.88%+27.99%+324.59% 30.37B
-1.29%+3.10%-25.85%-43.04% 7.04B
+1.20%+7.18%+1.08%+89.89% 4.46B
-4.65%+12.19%+24.88%-25.62% 1.79B
+2.68%+19.47%-7.48%+745.42% 1.78B
-1.98%+3.16%-13.11%-65.92% 1.73B
-1.71%+1.92%+12.46%-6.88% 1.63B
-0.56%+22.92% - - 1.53B
+0.13%+0.73%+48.85%-32.08% 1.45B
Average -0.22%+5.11%+8.70%+116.46% 5.46B
Weighted average by Cap. +0.99%+2.99%+15.06%+211.80%

Financials

2026 2027 *
Net sales 27.43B 290M 250M 230M 216M 406M 410M 2.72B 1.06B 13.43B 1.09B 1.07B 46.47B 31.34B 332M 286M 263M 247M 463M 468M 3.11B 1.21B 15.35B 1.24B 1.22B 53.1B
Net income 5.04B 53.28M 45.92M 42.26M 39.65M 74.47M 75.22M 500M 195M 2.47B 200M 196M 8.53B 5.91B 62.5M 53.87M 49.58M 46.51M 87.37M 88.24M 586M 229M 2.89B 235M 230M 10.01B
Net Debt -12.26B -130M -112M -103M -96.53M -181M -183M -1.22B -475M -6B -487M -476M -20.77B -14.9B -158M -136M -125M -117M -220M -223M -1.48B -578M -7.3B -592M -579M -25.26B
Logo Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services. The Company is engaged primarily in the business of running laboratories for carrying out pathological investigations in various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests, including Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and vitamin D Test. It has approximately 298 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab in Kolkata, Bangalore and Mumbai), 6,607 patient service centers, and 12,365 pick-up points (PUPs). Its customers include individual patients, hospitals, and corporate customers.
Employees
4,980
Calendar
Date Price Change Volume
26-06-15 1,616.00 +0.91% 217,507
26-06-12 1,601.50 +0.50% 192,359
26-06-11 1,593.50 +1.58% 369,662
26-06-10 1,568.70 -0.45% 184,518
26-06-09 1,575.80 +1.93% 126,213
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
1,616.00INR
Average target price
1,686.00INR
Spread / Average Target
+4.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LALPATHLAB Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!